The global CRO services market is estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of clinical trials, high cost of in-house drug development (encouraging pharma-biotech companies to opt for outsourcing), and the rising prevalence of orphan and rare diseases (creating new revenue pockets for CROs).
The data management services segment accounted for the highest growth rate in the CRO services market, by type, during the forecast period In 2021, the data management services segment accounted for the highest growth rate.The data management services segment is projected to grow at the highest CAGR owing to the need for the generation of high-quality and statistically sound data and its management and the rising importance of data handling in order to meet regulatory requirements.
Data management is critical for smooth and uninterrupted flow and easy access of data during the development of drugs and medical devices.
Asia Pacific: The fastest-growing region in the CRO services market The Asia Pacific market is estimated to record the highest CAGR during the forecast period. This is attributed to the rapid growth in the pharmaceutical and biopharmaceutical industries, low cost of clinical trials, implementation of favorable government policies, and the rising number of CROs in the region.
The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side- 70% and Demand Side 30% • By Designation: C-level - 45%, D-level - 30%, and Others - 25% • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report: • IQVIA Inc. (US) • Laboratory Corporation of America Holdings (US) • Charles River Laboratories International Inc. (US) • WuXi AppTec Co. Ltd. (China) • Syneos Health Inc. (US) • PPD, Inc. ( a part of Thermo Fisher Scientific, Inc.) • Parexel International Corporation (US) • ICON plc (Ireland) • Medpace Holdings Inc. (US) • SGS SA (Switzerland) • BioAgile Therapeutics Pvt. Ltd. (India) • Firma Clinical Research, LLC (US) • AccuLab Life Sciences (US) • Novotech Health Holdings (Australia) • Geneticist Inc. (US) • Linical Americas (US) • Celerion (US) • Azelix LLC (US) • Pepgra Healthcare Pvt. Ltd. (UK) • Dove Quality Solutions Limited (UK) • Frontage Holdings Corporation (US) • PSI CRO AG (Switzerland) • Pharmaron Beijing Co., Ltd. (China) • Clinipace Inc. (US) • Axcent Advanced Analytics (US) • Clinical Trial Service BV (Netherlands)
Research Coverage: This report provides a detailed picture of the global Contract Research Organization (CROs) Services Market.It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region.
The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Contract Research Organization (CROs) Services Market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, challenges, trends, and opportunities.
Our reports have been used by over 10K customers, including:
Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products.Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services...
Toll Like Receptor 8 (CD288 or TLR8) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Toll Like Receptor 8 - Drugs In Development, 2022’; Toll Like Receptor 8 (CD288 or TLR8) pipeline...
Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder - Drugs In Development, 2022, provides an overview...
Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Metabotropic glutamate receptor 1 (mGluR1) is a protein...
The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging...
The Artificial intelligence/AI in drug discovery Market is projected to reach USD 4.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 45.7% during the forecast period. The growth of this market is primarily driven by factors such as the need to control drug discovery & development costs and reduce the overall time taken in this...
175 pages •
By The Business Research Company
• Jun 2022
Major players in the contract research and manufacturing services (CRAMS) market are Boehringer Ingelheim International GmbH, Catalent Inc., Lonza Group Ltd., Pharmaceutical Product Development LLC, Baxter BioPharma Solutions, AbbVie, Grifols International S.A., and Dalton Pharma Services. The global contract research and manufacturing...
This IDC Perspective highlights the critical focus of the life science industry on leveraging Al and ML to accelerate drug discovery. It dwells upon some of the infrastructural challenges and complexities (including compute and storage) that the industry has been facing, provides an insight into the burgeoning and diverse market landscape...
The global early toxicity testing market reached a value of US$ 1.08 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1.79 Billion by 2027, exhibiting a CAGR of 8.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.